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Abstract 33 
 Infection with the apicomplexan parasite Plasmodium falciparum is a major cause of morbidity 34 
and mortality worldwide. One of the striking features of this parasite is its ability to remodel and 35 
decrease the deformability of host red blood cells, a process that contributes to disease. To further 36 
understand the virulence of Pf we investigated the biochemistry and function of a putative Pf S33 37 
proline aminopeptidase (PfPAP). Unlike other P. falciparum aminopeptidases, PfPAP contains a 38 
predicted protein export element that is non-syntenic with other human infecting Plasmodium species. 39 
Characterization of PfPAP demonstrated that it is exported into the host red blood cell and that it is a 40 
prolyl aminopeptidase with a preference for N-terminal proline substrates. In addition genetic deletion 41 
of this exopeptidase was shown to lead to an increase in the deformability of parasite-infected red cells 42 
and in reduced adherence to the endothelial cell receptor CD36 under flow conditions. Our studies 43 
suggest that PfPAP plays a role in the rigidification and adhesion of infected red blood cells to 44 
endothelial surface receptors, a role that may make this protein a novel target for anti-disease 45 
interventions strategies.  46 
 47 
Index Key Words: prolyl aminopeptidase; malaria; Plasmodium falciparum; erythrocyte 48 
deformability; cytoadherence   49 
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1. Introduction 50 
 Parasites of the genus Plasmodium are the causative agents of malaria, man’s most lethal 51 
parasitic disease.  The World Health Organization estimates there were approximately 200 million clinical 52 
cases and 440,000 deaths due to malaria in 2015 (World Health Organization, 2015). While six 53 
Plasmodium species can infect humans, Plasmodium falciparum (Pf) is responsible for the majority of 54 
the morbidity and mortality of this disease (World Health Organization, 2015). The virulence of Pf 55 
malaria, while multi-faceted and not completely understood, is known to be associated with this 56 
parasite’s ability to mediate the adherence of infected host red blood cells (RBCs) to the endothelium 57 
of micro-capillaries causing obstruction and preventing splenic clearance (Miller et al., 2002; 58 
Watermeyer et al., 2016). In essence Pf remodels host RBCs to facilitate endothelium adherence 59 
(reviewed in (Maier et al., 2009)). Remodeling involves the transport and deposition of exported 60 
parasite proteins including Pf erythrocyte membrane protein (PfEMP) 1 and knob-associated histidine-61 
rich protein (KAHRP) to the host cell membrane (Maier et al., 2009; Watermeyer et al., 2016). RBC 62 
cytoskeletal modifications also occur (Cyrklaff et al., 2011; Shi et al., 2013). These host RBC 63 
modifications result in changes to RBC surface topology, membrane fluidity, permeability, 64 
adhesiveness and deformability (Aikawa, 1997; Atkinson and Aikawa, 1990; Cooke et al., 2004; 65 
Glenister et al., 2002; Maier et al., 2009; Nash et al., 1989; Watermeyer et al., 2016). However, the 66 
mechanisms driving all of these modifications remain unclear. 67 
 To further understand Pf mediated RBC remodeling and the virulence of Pf we have 68 
investigated the biochemistry and function of a putative S33 proline aminopeptidase (PfPAP). Unlike 69 
other plasmodial aminopeptidases (www.plasmodb.org) (Schoenen et al., 2010), PfPAP contains a 70 
predicted protein export element (PEXEL) (Marti et al., 2004) with the pentameric consensus sequence 71 
RILCD which is involved in facilitating the transport of parasite proteins into the host RBC. It is also 72 
non-syntenic with other human infecting Plasmodium species, suggesting a function unique to Pf 73 
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(www.plasmodb.org). While little is known about the biology and biochemical characteristics of S33 74 
prolyl aminopeptidases (PAPs), they specifically release amino-terminal proline residues from peptides 75 
and are present in a variety of organisms/cells, including fungi (Bolumar et al., 2003), bacteria 76 
(Yoshimoto et al., 1999), plants (Waters and Dalling, 1983) and bovine kidney (Khilji et al., 1979). In 77 
addition they have been reported to act as virulence factors in some fungi which appear to use this 78 
exopeptidase to degrade proline-rich host proteins, such as collagen (Felipe et al., 2005). PfPAP is a 79 
473 amino acid protein characterized by an alpha/beta-hydrolase signature domain (aa 139-449) and an 80 
abhydrolase_1 alpha/beta hydrolase fold (aa 195-275). It also contains a PAP motif (aa 140-286), 81 
including the catalytic triad (S249, D402, H430) common to serine exopeptidase aminopeptidases. It is 82 
encoded by PF3D7_1401300, a two exon gene, with a predicted mRNA sequence of 1422 bp. 83 
Interestingly, PF3D7_1401300 is located on the left arm of chromosome 14 (www.plasmodb.org), in a 84 
region containing other genes whose protein products are exported into the RBC (Kyes et al., 1999).  85 
 86 
2. Materials and Methods 87 
2.1 In silico modeling  88 
 The protein sequence of PfPAP was retrieved from PlasmoDB (www.plasmodb.org) using the 89 
gene ID PF3D7_1401300; a putative aminopeptidase. The sequence was aligned against a validated 90 
PAP from Serratia marcescens, PDB code 1QTR (Yoshimoto et al., 1999) using ClustalX (Larkin et 91 
al., 2007). No similarity was identified for the N-terminal PEXEL region of PF3D7_1401300 so this 92 
region was omitted to simplify the homology alignment and modelling process as well as to accelerate 93 
molecular dynamics simulations. A preliminary theoretical structural model of the protein was obtained 94 
by submission of the PEXEL truncated PF3D7_1401300 protein sequence to SwissModel, a fully 95 
automated protein structure homology-modelling server (http://swissmodel.expasy.org/). The initial 96 
structural refinement obtained automatically from within the SwissModel system was followed by a 97 
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comprehensive explicit solvent molecular dynamics simulation using periodic boundary water 98 
solvation and Particle mesh Ewald periodic electrostatic potentials for a total of 2 ns at 310 K, using the 99 
free parallel molecular dynamics code NAMD - a program designed and optimized for the high 100 
performance simulation of large biomolecular systems (Phillips et al., 2005). 101 
 102 
2.2 Recombinant PfPAP 103 
 Functional expression of PfPAP was achieved using a truncated form of the enzyme lacking the 104 
PEXELated N-terminal Asn-rich repeat region (aa 1-92). This truncated coding sequence was 105 
chemically synthesized by GenScript (NJ, USA) using codons optimized for expression in Eschericia 106 
coli from the PlasmoDB annotated mRNA sequence (for PF3D7_1401300). The gene was cloned into 107 
the pTrcHis2B expression vector (Invitrogen, USA) and the construct verified by sequencing before 108 
transforming into Rosetta 2 BL21 cells. The cells were grown in 2YT media up to an OD of 0.6 and 109 
protein expression induced with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) for 3 h at 30°C. 110 
Cells were lysed in 50 mM TrisHCl pH 7.5 containing 150 mM NaCl and 10 mM imidazole and 111 
extracted and solubilized with lysozyme and sonication. Hexa-histidine tagged recombinant PfPAP was 112 
purified on a Ni-NTA-agarose column as previously described (Stack et al., 2007). 113 
 114 
2.3 Enzymatic analysis  115 
 Recombinant PfPAP activity and substrate specificity were determined by measuring the 116 
release of the fluorogenic leaving group, 7-amino-4methyl-coumarin (NHMec) from the peptide 117 
substrate H-Pro-NHMec. Reactions were carried out in 96-well microtiter plates (100 µl total volume, 118 
30 min, 37°C) using a multi-detection plate reader (BMG LABTECH FLUOstar OPTIMA) with 119 
excitation at 370 nm and emission at 460 nm. Initial rates were obtained over a range of substrate 120 
concentrations (1-2000 µM) and at fixed enzyme concentration in 50 mM TrisHCl, pH 7.5. The pH 121 
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profile for recombinant PfPAP was determined from the initial rates of H-Pro-NHMec hydrolysis 122 
carried out in constant ionic strength (I = 0.1 M) with acetate/Phosphate/Tris buffers, pH (5-10). 123 
Recombinant PfPAP activity against the substrates H-Ala-NHMec, H-Leu-NHMec and H-Glu-NHMec 124 
was also examined. 125 
 126 
2.4 Antibody production  127 
 Antibodies to recombinant PfPAP were generated in Balb/c and C57/B6 mice by intraperitoneal 128 
injection of 50 µg of purified recombinant protein per mouse in 50 µl PBS mixed with an equal volume 129 
of complete Freund’s adjuvant. This was followed by a further two immunizations at two week 130 
intervals with 50 µg recombinant protein in 50 µl PBS and an equal volume of incomplete Freund’s 131 
adjuvant. Two weeks after the last injection test bleeds were performed and antibody titers to the 132 
recombinant protein measured by enzyme linked immuno-sorbent assay. Mice were then euthanized 133 
and blood collected by cardiac puncture.  134 
 135 
2.5 Parasites 136 
 The Pf parasite clones 3D7 and D10 were cultured in vitro in Roswell Park Memorial Institute 137 
(RPMI) medium supplemented with 10% human serum as previously described (Trager and Jensen, 138 
1976). RBCs and pooled serum were obtained from the Red Cross Transfusion Service (Brisbane, 139 
QLD, Australia). Pf3D7 is a cytoadherent Pf clone possessing a complete chromosome 9, while D10 is 140 
a non cytoadherent Pf clone lacking the right arm of chromosome 9.  141 
 142 
2.6 Northern blotting 143 
Northern blotting was performed with total RNA extracts prepared using TRIzol (Invitrogen) as 144 
previously described (Kyes et al., 2000). Blots were probed with a purified 1504 bp PCR fragment 145 
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corresponding to the full length genomic copy of PfPAP amplified from genomic Pf DNA using 146 
primers PAPF (ATGAGAAATATTAATGGGT) and PAPR (TGTTTTATATTGACCATTTTT). 147 
Probes were labelled with [α-32P] dATP by random priming (DECAprime II, Ambion Inc). The probe 148 
was hybridized overnight at 40oC in a hybridization buffer containing formamide (Northern Max; 149 
Ambion). The filter was washed once at low stringency and twice at high stringency (Northern Max; 150 
Ambion), then exposed to film overnight. 151 
 152 
2.7 Quantitative real-time PCR 153 
 The stage specific expression of PfPAP was examined by reverse transcription-quantitative 154 
polymerase chain reaction (RT-qPCR).  The Pf clonal line 3D7 was synchronized using two rounds of 155 
sorbitol treatment (Lambros and Vanderberg, 1979) (>99% early ring stage parasites) and parasites 156 
samples harvested at 0, 12, 18, 24, and 36 h. Transcript levels were assessed by extracting total RNA as 157 
previously described (Kyes et al., 2000) and generating cDNA (QuantiTect Reverse Transcription Kit, 158 
Qiagen). Quantitative PCR was performed using a Rotor-Gene 6000 real time PCR Cycler (Corbett 159 
Research/Qiagen, Australia). Briefly cDNA was added to SYBR Green PCR Master-mix (Applied 160 
Biosystems, Australia) together with PfPAP specific primers (forward 161 
TCACCCGTTGGTGTATTGAA and reverse TGGTTACCACCATTCCCAAT) or internal reference 162 
primers (18s rRNA; PF3D7_0725600, forward CGGCGAGTACACTATATTCTTA and reverse 163 
TTAGTAGAACAGGGAAAAGGAT (Augagneur et al., 2012) or Seryl-tRNA synthetase, 164 
PF3D7_0717700, forward ATAGCTACCTCAGAACAACC and reverse 165 
CAAGATGAGAATCCAGCGTA (Roseler et al., 2012). Each run was performed in triplicate and 166 
repeated twice. Data were analysed with Rotor-Gene 6.0 software with PfPAP transcription calculated 167 
relative to both reference genes using the standard curve method and presented as mean + SEM 168 
(Corbett Research/Qiagen, Australia).  169 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
 170 
2.8 Construction of the transgenic expression plasmids and parasites 171 
 PF3D7_1401300 was PCR amplified from Pf clone D10 genomic DNA using the forward 172 
primer PAPBglF (AGATCTATGAGAAATATTAATGGGT; containing a BglII restriction site, in 173 
bold) and the reverse primer PAPPstR (CTGCAGTGTTTTATATTGACCATTTTT; containing a PstI 174 
restriction site, in bold). The PCR product was cloned into pGEM using a TA cloning system 175 
(Promega, USA) and sequenced to confirm that no Taq-associated errors had occurred. Full length 176 
fragments were digested out of the pGEM vector using BglII and PstI and subcloned into the 177 
previously digested (using BglII and PstI) GatewayTM (InvitroGen) compatible entry vector pHGFPB . 178 
In this vector the introduced gene is ligated in frame with a  3’ green florescent protein (GFP)-tag under 179 
the control of the heat shock protein 86 promoter (Dixon et al., 2008). This entry vector was designated 180 
pHB-PF1401300-GFP. A clonase reaction was then performed using this entry vector and a GatewayTM 181 
compatible destination vector with a destination cassette and a second cassette containing the human 182 
dihydrofolate reductase synthase gene under the control of the Pf calmodulin promoter as a selectable 183 
marker (conferring resistance to the anti-folate drug, WR92210). The final plasmid was designated 184 
pHH1-PF1401300-GFPB. For transfection, ring stage parasites were subjected to electroporation in the 185 
presence of 50 µg of plasmid DNA as described (Wu et al., 1995). Parasites resistant to WR99210 were 186 
obtained <25 days later.  187 
 188 
2.9 Creation of knockout parasite clones  189 
 A transfection vector intended to disrupt the PfPAP gene by double homologous recombination 190 
was designed using a positive negative selection strategy. This vector had previously undergone 191 
extensive modifications for use with the GatewayTM Cloning system. In the original modification the 192 
human dihydrofolate reductase synthase gene was used for positive selection and the Herpes simplex 193 
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thymidine kinase (tk) gene used for negative selection (sensitivity to ganciclovir). However in the 194 
current vector the tk gene was removed and replaced with the cytosine deaminase gene of Escherichia 195 
coli. This entry vector was then further modified by the addition of an AvrII site 10 bp from the unique 196 
SalI site upstream of the heat shock protein 86 promoter, allowing the insertion of the 5′-targeting 197 
sequence by directional cloning. The destination vector contained the human dihydrofolate reductase 198 
synthase gene under the control of the Pf calmodulin promoter and, downstream, the unique AvrII/ClaI 199 
cloning site. The 3′-targeting sequence was inserted into this site via directional cloning. A clonase 200 
reaction of the entry and destination vectors produced the final transfection vector (pHH1-201 
PfPAPDKO). Plasmid DNA was generated and transfected into Pf 3D7 parasites as previously 202 
described.  Parasites resistant to WR92210 were detected 30 days post transfection. Parasites were 203 
cycled on both WR99210 and 5-fluoro-uracil until integration of the vector into the genomic copy of 204 
the PfPAP gene was detected by PCR. These cultures were cloned by limiting dilution. 205 
 The pHH1-PfPAPDKO transfection vector contained a 5`-targeting sequence generated by PCR 206 
amplification of DNA from Pf clone 3D7 using the primers PAPDKO5F 207 
(CCTAGGCTTAAGTACATATGATAAACT) and PAPDKO5R (GTCGACAGGTTCAAATG 208 
CTTTAATAAT). Restriction endonuclease sites are listed in bold. This generated a 739 bp fragment 209 
that was cloned into a pGEM Teasy vector (Promega), and sequenced. Digestion of this vector with the 210 
appropriate restriction endonucleases allowed directional cloning of the fragment into the entry vector. 211 
For the 3` targeting sequence a 641 bp PCR fragment was generated using the primers PAPDKO3F 212 
(ATCGATTGGG ATGTATAATAGCCGCAG) and PAPDKO3R (CCTAGGTTA-213 
TCAATAGTAATCTGTTT). This PCR fragment was cloned into a pGEM Teasy vector (Promega), 214 
and sequenced to confirm the sequence. Digestion of this vector with the appropriate restriction 215 
endonucleases allowed directional cloning of the fragment into the destination vector.  216 
 217 
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2.10 Western Blotting 218 
After washing infected RBCs in phosphate-buffered saline (PBS), parasites were released by 219 
incubation with 0.03% saponin in PBS at 4oC. Resulting parasite pellets were washed three times with 220 
PBS then lysed in distilled H2O for 2 min, followed by centrifugation at 14,000 g. Parasite supernatants 221 
were stored at 4oC. Proteins of saponin-lysed parasite extracts were resolved on reducing 10% SDS-222 
PAGE gels, transferred to a nitrocellulose membrane and probed with the anti-PfPAP antisera (1:250 223 
dilution) followed by a horseradish peroxidase-labelled anti-mouse IgG antibody (1:5000 dilution, 224 
Chemicon International Inc.). The membrane was stripped and re-probed with an anti-glyceraldehyde-225 
3-phosphate-dehydrogenase (GAPDH) rabbit antibody (1:5000 dilution) to demonstrate transfer of 226 
malaria proteins (Spielmann et al., 2006). 227 
 228 
2.11 Fluorescence Microscopy 229 
 Fluorescence and phase contrast images were collected with an Axioscope 2 Mot + (Zeiss) 230 
equipped with a Zeiss 63x/1.4 Plan Apochromat lens. Live parasites were mounted in PBS and 231 
observed at ambient temperature. Parasite DNA was visualized by adding Hoechst dye (0.5 µg/ml) and 232 
incubating at 37oC for 10 min prior to mounting. For indirect fluorescence, concanavalin A (0.5 mg/ml) 233 
was added to each well of a multi-well slide and incubated for 30 min at 37oC after which infected 234 
RBCs were added, incubated at room temperature for 15 min and unbound cells removed by washing 235 
with PBS. The cells were fixed in 4% formaldehyde/0.005% glutaraldehyde and probed with anti-236 
PfPAP anti-serum or with a mouse monoclonal antibody to GFP (diluted 1:500). Bound antibody was 237 
visualized with goat anti-mouse Ig-Cy2 (10 µg/ml). Immunofluorescence assays for the detection of 238 
KAHRP, Ring-exported protein-1 (REX1), and PfEMP-3 were performed as previously described 239 
(Dixon et al., 2008). Briefly, thin blood smears of trophozoite stage parasites were made for both parent 240 
and PfPAP knockout (PAPKO) cells, air dried and fixed in cold acetone for 10 min. Slides were 241 
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washed in 1X PBS and all antibody incubations were performed in 3% BSA 1X PBS for 1 h at room 242 
temperature. The following primary antibodies were used: anti-KAHRP mouse (1:500), anti-PfEMP-3 243 
mouse (1:500) and anti-REX1 rabbit (1:2000). Slides were washed three times in 1X PBS prior to 244 
addition of anti-rabbit FITC and anti-mouse Alexa Fluor 647. Secondary antibodies were washed from 245 
the slides and the nuclei stained with 10 µg/ml of 4',6-diamidino-2-phenylindole (DAPI) prior to 246 
mounting of slides. Images were taken on a Delta Vision (DV) Elite Microscope with 100X oil 247 
objective. Images were processed using NIH ImageJ version 1.48c (http://imagej.nih.gov/ij/). 248 
 249 
2.12 Atomic force microscopy 250 
 To investigate the mechanical properties of the infected and uninfected RBCs, arrays of 20 x 20 251 
force curves on a 10 x10 µm area were recorded on samples immersed in PBS employing an MFP-3D 252 
(Asylum Research) atomic force microscope (AFM) in force spectroscopy mode. The AFM was 253 
mounted on an anti-vibrational table (Herzan) and operated within an acoustic isolation enclosure 254 
(TMC, USA). The force curves were recorded using a SiNi cantilever (Budget Sensors, Bulgaria) 255 
having a nominal spring constant KN = 0.06 N/m. Prior to use the cantilevers had been calibrated 256 
against a glass slide, using the thermal vibration method embedded in the AFM processing software. 257 
All experiments were repeated 4 times in triplicate with the loading force kept constant at 20 nN and 258 
the velocity at 1 µm/s. Force curve data were analysed using IGOR software. The Young’s modulus, E, 259 
(+ SD) was calculated using the Hertz model.  260 
 261 
2.13 Spleen mimic filtration  262 
 Parent 3D7 and 3D7-PAPKO parasites were synchronized to a 2 h window (Lambros and 263 
Vanderberg, 1979). Spleen mimic filtration was performed as previously described (Deplaine et al., 264 
2011). Briefly, parasite infected RBCs at 5% parasitemia were re-suspended at 1% hematocrit in 1% 265 
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AlbuMax II in PBS. The solution was flowed over a 5 mm bead volume of calibrated metal microbeads 266 
ranging in size from 5-25 µm at a rate of 60 ml/h. The percentage parasitaemia pre and post filtration 267 
was assessed via Giemsa stained thin blood films and used to calculate the percentage of parasites 268 
present in the flow through (% flow). Three biological repeats were performed. 269 
 270 
2.14 Cytoadherence assays 271 
 Cytoadherence assays were performed using prefabricated slides (ibidi GmbH). Slides were 272 
coated with 125 µg/ml of recombinant CD36 in PBS overnight prior to blocking with 1% BSA for 1 h 273 
at 37oC. The slides were washed with RPMI-HEPES (minus NaHCO3). All assays were performed on a 274 
DV elite microscope with environmental chamber set at 37oC. 275 
 Parasite infected RBCs at 3% parasitemia and 1% haematocrit in RPMI-HEPES (minus 276 
NaHCO3) were flowed through the chamber for 5 min at a pressure of 0.1 or 0.05 Pa prior to a further 277 
washing (5 min) with RPMI-HEPES (minus NaHCO3). Washing and counting was performed under 278 
the same conditions as binding. The number of parasite infected RBCs bound in 20 fields were 279 
counted, and expressed as parasites bound per mm2 (Crabb et al., 1997). Three biological repeats were 280 
performed. 281 
 282 
2.15 Electron microscopy 283 
 Parasite infected RBCs were embedded in 1% molten agarose in 0.1 M phosphate buffer. The 284 
agarose blocks were processed into Epon resin using a Pelco 34700 Biowave Microwave Oven (Ted 285 
Pella Inc., Redding, CA). Cells were post-fixed in aqueous potassium ferricyanide-reduced osmium 286 
tetroxide and dehydrated in ethanol prior to infiltration and embedment in Epon resin. Unstained 287 
ultrathin sections were observed and photographed using a JEOL 1011 transmission electron 288 
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microscope (JEOL Ltd, Tokyo, Japan) equipped with an Olympus Morada side-mounted digital camera 289 
(Olympus, USA). 290 
 291 
3. Results 292 
3.1 In silico modeling of PfPAP 293 
 While no malaria parasite PAP structures currently exist in the protein data bank (PDB), X-ray 294 
derived solid-state structures of several other validated PAPs have been determined 295 
(http://www.rcsb.org (Berman et al., 2000)). To provide additional evidence that PfPAP is indeed a 296 
PAP its amino acid sequence was aligned with a validated PAP derived from Serratia marcescens 297 
(Yoshimoto et al., 1999) (PDB code 1QTR; Fig 1, panels A, B and C; 41% similarity with PfPAP; with 298 
specific N-terminal PEXEL sequence removed). Co-alignment of catalytically significant triad residues 299 
(Ser249, Asp402, His430) and other highly conserved residues, characteristic of PAPs, provided further 300 
evidence that PfPAP belongs to this class of protein (Fig 1A). The primary sequence similarity 301 
observed in the alignment was also observed in the structural homology model.  Comparison of the 302 
PfPAP structural model with the X-ray derived structure of S. marcescens PAP (PDB code 1QTR) 303 
revealed that the spatial distributions of catalytic residues and other notable residues (Fig 1C) are 304 
highly conserved, further supporting the proposed function of PF3D7_1401300. 305 
 306 
3.2 Biochemical characterization of functionally active recombinant PfPAP 307 
 PfPAP was expressed and purified as a recombinant protein (rPfPAP) from bacterial cells. The 308 
enzyme resolved as a single protein of ~45 kDa (Fig 2A) and immunoblotting confirmed expression of 309 
the recombinant protein (Fig 2B). Using the fluorogenic substrate H-Pro-NHMec (7-amido-4-310 
methylcoumarin), rPfPAP exhibited a Km of 403 µM and a Kcat/Km value 28.28 M-1 s-1 (Fig 2C). 311 
Experiments investigating the specificity of rPfPAP demonstrate a low, but significant, level of activity 312 
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when incubated with the fluorogenic substrate H-Ala-NHMec (2-5% compared to H-Pro-NHMec) but 313 
no hydrolysis of H-Leu-NHMec or H-Glu-NHMec. When the metal chelator o-phenanthroline (2 mM) 314 
was added, only slight inhibition of rPfPAP activity was observed, confirming the activity is specific 315 
and not due to contaminating bacterial neutral aminopeptidases (not shown). 316 
 317 
3.3 PfPAP is transcribed throughout the intraerythrocytic asexual lifecycle and exported into 318 
the host RBC 319 
 Northern blot analysis indicated that Pf transcribes a single species of mRNA with an apparent 320 
size of ~3 kbp throughout the intraerythrocytic life cycle (Fig 3A). Quantitative analysis of 321 
transcription suggested that peak expression occurs early in development (Fig 3B). 322 
  Western blot analysis of parent 3D7 parasites with anti-PfPAP antiserum revealed a single 323 
species with an apparent molecular weight (MW) of ~40 kDa (Fig 3C). Immunochemistry using an 324 
anti-GFP antibody on a transgenic GFP-tagged PfPAP chimeric protein also identified a single protein 325 
species (not shown). Immunofluorescence analysis using anti-PfPAP antibody localized PfPAP to the 326 
infected RBC cytoplasm which was confirmed in GFP-tagged PfPAP transfected parasites (Fig 3D). 327 
 328 
3.4 Targeted gene disruption (TGD) of PfPAP changes the viscoelastic properties of the 329 
infected RBC membrane 330 
  PCR analysis indicated that a single homologous recombination of the 5` targeting sequence 331 
had occurred in the clone selected for further study. Nonetheless this led to a truncation of the genomic 332 
copy and Western blot analysis using antibodies to rPfPAP indicated loss of PfPAP expression (Fig 333 
3C).  334 
 Genetic disruption of PF3D7_1401300 caused no obvious changes in macroscopic phenotype, 335 
including life cycle length, or in parasite viability in vitro. However, significant changes in the 336 
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viscoelastic properties of the infected RBC plasma membrane were observed using AFM. The Young’s 337 
modulus value (E) was determined to be 760 + 140 kPa for uninfected RBCs, and 1760 + 710 kPa for 338 
3D7 early trophozoite infected RBCs. However, 3D7_PAP-KO early trophozoite –infected RBCs 339 
generated a Young’s modulus value of 800 + 250 kPa. . 340 
 A microbead filtration system that mimics the splenic microcirculation was employed to assess 341 
RBC deformability changes in more detail (Fig 4A). Tightly synchronized parasites were analyzed 16, 342 
18, 20 and 26 h post invasion. No significant difference between the percentage of 3D7 and 3D7_PAP-343 
KO parasites in the flow through was seen at 16 h (64 ± 14% vs 58 ± 6%; relative to starting 344 
parasitemia). However, 3D7_PAP-KO parasites were significantly more filterable than 3D7 parasites at 345 
18 to 26 h post-invasion (18 h: 64 ± 4% vs 41 ± 5%; 20 h: 58 ± 6% vs 26 + 3%; and 26 h: 40 ± 5% vs 346 
21 + 3%; P = 0.0001) (Fig 4A).  347 
 The impact of PfPAP TGD on the expression and transport of proteins thought to play a role in 348 
the trafficking of unique Pf cytoadherence proteins, such as PfEMP-1, to the infected RBC surface was 349 
assessed. Data demonstrated that TGD of PfPAP does not change the location of KAHRP, ring-350 
exported protein-1 (REX1), skeleton-binding protein-1 (SBP1) or PfEMP-3. Each of these proteins was 351 
found at the RBC membrane or Maurer’s clefts of 3D7 and 3D7PAPKO parasites (Fig 4B). Electron 352 
microscopy also confirmed the presence of electron dense structures at the infected RBC plasma 353 
membrane of both 3D7 (not shown) and 3D7PAPKO parasites (Fig 4C), consistent with correct 354 
trafficking and delivery of KAHRP.  355 
The presence of PfEMP-1 at the surface of both 3D7 and 3D7PAPKO parasites was 356 
demonstrated by trypsin cleavage (Fig 5A). Cleavage products (75-100 kDa) were observed in trypsin-357 
treated (T) samples but were absent from samples with no trypsin (P) or with trypsin plus inhibitor (i) 358 
(Fig 5A). Consistent with these data parent 3D7 and 3D7_PAP-KO infected RBCs adhered to 359 
recombinant CD36 at similar levels under static conditions (Fig 5B). However, assessment of binding 360 
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under physiological flow conditions demonstrated that 3D7 infected RBCs bound at 500 ± 20 infected 361 
RBC/mm2 while the 3D7_PAP-KO infected RBCs bound at a significantly lower rate (367 ± 16 362 
infected RBC/mm2; P < 0.0001). This significant decrease in binding was also seen at the higher shear 363 
stress of 0.1 Pa. (Fig 5C).  364 
 365 
4. Discussion 366 
 In this work PF3D7_1401300-encoded PfPAP was verified as an aminopeptidase with a 367 
preference for N-terminal proline substrates and with a weaker specificity for substrates containing N-368 
terminal alanine. While the fine specificities of various S33 clan members can vary, a weak specificity 369 
for N-terminal alanine is not uncommon in this group of enzymes. PAPs are not obligate proline 370 
aminopeptidases, with members being capable of cleaving additional residues including alanine 371 
(Mahon et al., 2009). A sequence comparison of PfPAP with the well described PAP protein from 372 
Serratia marcescens (PDB code 1QTR) (Fig 1, panels A, B and C) also demonstrated the conserved 373 
location of catalytic triad residues in PfPAP.  374 
Particularly interesting features of PfPAP are that it is unique to Pf and contains a protein export 375 
element (PEXEL) or vacuolar transit sequence (VTS) (www.plasmo.db.org). The presence of an export 376 
sequence suggests that unlike all other characterised Pf aminopeptidases, this enzyme is transported 377 
into the RBC cytoplasm. One of the important functions of exported proteins is to modify the host RBC 378 
membrane to facilitate adhesion to blood vessel walls, an event that underlies much of the 379 
pathophysiology of Pf infections. For example a number of exported parasite proteins facilitate the 380 
presentation of the adhesin, PfEMP-1, at the RBC surface. They achieve this by reorganizing the host 381 
RBC membrane skeleton and by forming raised structures, known as knobs. The surface presentation 382 
of PfEMP-1 at the knobby protrusions facilitates binding to endothelial receptors, such as CD36 (Crabb 383 
et al., 1997). Intra-erythrocytic maturation of Pf is also associated with RBC membrane rigidification 384 
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(Glenister et al., 2002). While KAHRP and PfEMP-3 are responsible for about 50% of the observed 385 
rigidification (Glenister et al., 2002), it is recognized that other structural proteins and enzymes can 386 
contribute to the reorganization of the membrane skeleton and rigidification (Glenister et al., 2002; 387 
Sanyal et al., 2012).  388 
To investigate the role of PfPAP in RBC re-modelling and cytoadherence we examined the 389 
expression and location of PfPAP within infected RBCs. We also performed a TGD of PfPAP. In these 390 
studies the expression of PfEMP-1, REX1, KAHRP and PfEMP-3 was examined as was host RBC 391 
rigidity, deformability and CD36-mediated cytoadherence. Our data demonstrated that PfPAP is 392 
exported into the host RBC cytoplasm (Fig 3D) and that it is highly expressed early in the parasite 393 
asexual intra-erythrocytic life cycle (Fig 3B), characteristics that support a role in RBC remodeling. 394 
They also showed that while static CD36-mediated adhesion is not changed by PfPAPKO, adherence is 395 
weaker under flow conditions (Fig 5). In addition the rigidity and filterability (Fig 4) of host RBCs 396 
infected with parasites no longer able to express PfPAP is reduced when compared to wild-type 397 
parasites. Interestingly TGD of PfPAP had no impact on the delivery of KAHRP or PfEMP-3 to the 398 
RBC membrane skeleton (Fig 4). It also had no impact on the delivery of REX1 or PfEMP-1 to their 399 
known locations in the Maurer’s clefts and RBC surface respectively (Figs 4 and 5).  400 
While the precise role of the PfPAP remains to be elucidated, current data suggest that this 401 
protein plays a role in host RBC re-modelling independent of PfEMP-1, PfEMP-3, KAHRP and REX1 402 
and that this role results in reduced RBC rigidity and cytoadherence under flow conditions. These data 403 
fit well with the non-essential nature of PfPAP in vitro where parasites are not dependent on 404 
cytoadherence and RBC deformability to survive. The ability of parasites to cytoadhere and avoid 405 
splenic clearance in vivo is of no advantage to parasites in vitro. Nevertheless, caution must be 406 
exercised before drawing firm conclusions in this regard. The current study did not investigate the 407 
expression of STEVOR (subtelomeric variant open reading frame) proteins in wild-type and transgenic 408 
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parasites and recent studies have demonstrated that these proteins play a role in the deformability of 409 
host RBCs infected with Pf gametocytes and asexual stages (Sanyal et al., 2012; Tiburcio et al., 2012). 410 
In addition, while the PfEMP-1 variant expressed by both wild-type and PfPAPKO parasites in this 411 
study demonstrated a comparable preference for CD36 under static conditions (Fig 5) further studies 412 
examining the impact of these variant proteins on RBC deformability and adherence under shear flow 413 
conditions were not performed, however care was taken to ensure that CD36 specific PfEMP-1 binding 414 
variants were expressed by panning of parasites to CD36. 415 
The current study verified PF3D7_1401300-encoded PfPAP as a PAP and has provided the first 416 
insights into the functional role of this exported protease. Although further work including the analysis 417 
of additional clones, an assessment of expressed stevor genes in clones and an assessment of the impact 418 
of var gene expression on this protein’s apparent role in RBC re-modelling is required to fully elucidate 419 
the role of PfPAP in modifying the host RBC and to determine its contribution to survival fitness in 420 
vivo, the current data suggest that drugs designed to inhibit PfPAP may be useful in preventing 421 
sequestration of the asexual stage in the micro-capillaries and warrants further investigation as an anti-422 
disease drug target.  423 
  424 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
Acknowledgements 425 
This work was supported by the National Health & Medical Research Council of Australia and the 426 
Australia Research Council (PD0666128). 427 
 428 
References 429 
Aikawa, M., 1997. Studies on falciparum malaria with atomic-force and surface-potential microscopes. 430 
Ann Trop Med Parasitol 91, 689-692. 431 
Atkinson, C.T., Aikawa, M., 1990. Ultrastructure of malaria-infected erythrocytes. Blood Cells 16, 432 
351-368. 433 
Augagneur, Y., Wesolowski, D., Tae, H.S., Altman, S., Ben Mamoun, C., 2012. Gene selective mRNA 434 
cleavage inhibits the development of Plasmodium falciparum. Proc Natl Acad Sci U S A 109, 6235-435 
6240. 436 
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., 437 
Bourne, P.E., 2000. The Protein Data Bank. Nucleic Acids Res 28, 235-242. 438 
Bolumar, T., Sanz, Y., Aristoy, M.C., Toldra, F., 2003. Purification and characterization of a prolyl 439 
aminopeptidase from Debaryomyces hansenii. Appl Environ Microbiol 69, 227-232. 440 
Cooke, B.M., Mohandas, N., Coppel, R.L., 2004. Malaria and the red blood cell membrane. Semin 441 
Hematol 41, 173-188. 442 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
Crabb, B.S., Cooke, B.M., Reeder, J.C., Waller, R.F., Caruana, S.R., Davern, K.M., Wickham, M.E., 443 
Brown, G.V., Coppel, R.L., Cowman, A.F., 1997. Targeted gene disruption shows that knobs enable 444 
malaria-infected red cells to cytoadhere under physiological shear stress. Cell 89, 287-296. 445 
Cyrklaff, M., Sanchez, C.P., Kilian, N., Bisseye, C., Simpore, J., Frischknecht, F., Lanzer, M., 2011. 446 
Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. 447 
Science 334, 1283-1286. 448 
Deplaine, G., Safeukui, I., Jeddi, F., Lacoste, F., Brousse, V., Perrot, S., Biligui, S., Guillotte, M., 449 
Guitton, C., Dokmak, S., Aussilhou, B., Sauvanet, A., Cazals Hatem, D., Paye, F., Thellier, M., Mazier, 450 
D., Milon, G., Mohandas, N., Mercereau-Puijalon, O., David, P.H., Buffet, P.A., 2011. The sensing of 451 
poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood 117, e88-95. 452 
Dixon, M.W., Hawthorne, P.L., Spielmann, T., Anderson, K.L., Trenholme, K.R., Gardiner, D.L., 453 
2008. Targeting of the ring exported protein 1 to the Maurer's clefts is mediated by a two-phase 454 
process. Traffic 9, 1316-1326. 455 
Felipe, M.S., Andrade, R.V., Arraes, F.B., Nicola, A.M., Maranhao, A.Q., Torres, F.A., Silva-Pereira, 456 
I., Pocas-Fonseca, M.J., Campos, E.G., Moraes, L.M., Andrade, P.A., Tavares, A.H., Silva, S.S., 457 
Kyaw, C.M., Souza, D.P., Pereira, M., Jesuino, R.S., Andrade, E.V., Parente, J.A., Oliveira, G.S., 458 
Barbosa, M.S., Martins, N.F., Fachin, A.L., Cardoso, R.S., Passos, G.A., Almeida, N.F., Walter, M.E., 459 
Soares, C.M., Carvalho, M.J., Brigido, M.M., PbGenome, N., 2005. Transcriptional profiles of the 460 
human pathogenic fungus Paracoccidioides brasiliensis in mycelium and yeast cells. J Biol Chem 280, 461 
24706-24714. 462 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
Glenister, F.K., Coppel, R.L., Cowman, A.F., Mohandas, N., Cooke, B.M., 2002. Contribution of 463 
parasite proteins to altered mechanical properties of malaria-infected red blood cells. Blood 99, 1060-464 
1063. 465 
Khilji, M.A., Akrawi, A.F., Bailey, G.S., 1979. Purification and partial characterisation of a bovine 466 
kidney aminotripeptidase (capable of cleaving prolyl-glycylglycine). Mol Cell Biochem 23, 45-52. 467 
Kyes, S., Pinches, R., Newbold, C., 2000. A simple RNA analysis method shows var and rif multigene 468 
family expression patterns in Plasmodium falciparum. Mol Biochem Parasitol 105, 311-315. 469 
Kyes, S.A., Rowe, J.A., Kriek, N., Newbold, C.I., 1999. Rifins: a second family of clonally variant 470 
proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proc Natl Acad Sci 471 
U S A 96, 9333-9338. 472 
Lambros, C., Vanderberg, J.P., 1979. Synchronization of Plasmodium falciparum erythrocytic stages in 473 
culture. J Parasitol 65, 418-420. 474 
Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, 475 
F., Wallace, I.M., Wilm, A., Lopez, R., Thompson, J.D., Gibson, T.J., Higgins, D.G., 2007. Clustal W 476 
and Clustal X version 2.0. Bioinformatics 23, 2947-2948. 477 
Mahon, C.S., O'Donoghue, A.J., Goetz, D.H., Murray, P.G., Craik, C.S., Tuohy, M.G., 2009. 478 
Characterization of a multimeric, eukaryotic prolyl aminopeptidase: an inducible and highly specific 479 
intracellular peptidase from the non-pathogenic fungus Talaromyces emersonii. Microbiology 155, 480 
3673-3682. 481 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
Maier, A.G., Cooke, B.M., Cowman, A.F., Tilley, L., 2009. Malaria parasite proteins that remodel the 482 
host erythrocyte. Nat Rev Microbiol 7, 341-354. 483 
Marti, M., Good, R.T., Rug, M., Knuepfer, E., Cowman, A.F., 2004. Targeting malaria virulence and 484 
remodeling proteins to the host erythrocyte. Science 306, 1930-1933. 485 
Miller, L.H., Baruch, D.I., Marsh, K., Doumbo, O.K., 2002. The pathogenic basis of malaria. Nature 486 
415, 673-679. 487 
Nash, G.B., O'Brien, E., Gordon-Smith, E.C., Dormandy, J.A., 1989. Abnormalities in the mechanical 488 
properties of red blood cells caused by Plasmodium falciparum. Blood 74, 855-861. 489 
Phillips, J.C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R.D., 490 
Kale, L., Schulten, K., 2005. Scalable molecular dynamics with NAMD. J Comput Chem 26, 1781-491 
1802. 492 
Roseler, A., Prieto, J.H., Iozef, R., Hecker, B., Schirmer, R.H., Kulzer, S., Przyborski, J., Rahlfs, S., 493 
Becker, K., 2012. Insight into the selenoproteome of the malaria parasite Plasmodium falciparum. 494 
Antioxid Redox Signal 17, 534-543. 495 
Sanyal, S., Egee, S., Bouyer, G., Perrot, S., Safeukui, I., Bischoff, E., Buffet, P., Deitsch, K.W., 496 
Mercereau-Puijalon, O., David, P.H., Templeton, T.J., Lavazec, C., 2012. Plasmodium falciparum 497 
STEVOR proteins impact erythrocyte mechanical properties. Blood 119, e1-8. 498 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
Schoenen, F.J., Weiner, W.S., Baillargeon, P., Brown, C.L., Chase, P., Ferguson, J., Fernandez-Vega, 499 
V., Ghosh, P., Hodder, P., Krise, J.P., Matharu, D.S., Neuenswander, B., Porubsky, P., Rogers, S., 500 
Skinner-Adams, T., Sosa, M., Spicer, T., To, J., Tower, N.A., Trenholme, K.R., Wang, J., Whipple, D., 501 
Aube, J., Rosen, H., White, E.L., Dalton, J.P., Gardiner, D.L., 2010. Inhibitors of the Plasmodium 502 
falciparum M18 Aspartyl Aminopeptidase, Probe Reports from the NIH Molecular Libraries Program, 503 
Bethesda (MD). 504 
Shi, H., Liu, Z., Li, A., Yin, J., Chong, A.G., Tan, K.S., Zhang, Y., Lim, C.T., 2013. Life cycle-505 
dependent cytoskeletal modifications in Plasmodium falciparum infected erythrocytes. PLoS One 8, 506 
e61170. 507 
Spielmann, T., Gardiner, D.L., Beck, H.P., Trenholme, K.R., Kemp, D.J., 2006. Organization of 508 
ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. Mol Microbiol 59, 779-509 
794. 510 
Stack, C.M., Lowther, J., Cunningham, E., Donnelly, S., Gardiner, D.L., Trenholme, K.R., Skinner-511 
Adams, T.S., Teuscher, F., Grembecka, J., Mucha, A., Kafarski, P., Lua, L., Bell, A., Dalton, J.P., 512 
2007. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved 513 
in amino acid regulation with potential for antimalarial drug development. J Biol Chem 282, 2069-514 
2080. 515 
Tiburcio, M., Niang, M., Deplaine, G., Perrot, S., Bischoff, E., Ndour, P.A., Silvestrini, F., Khattab, A., 516 
Milon, G., David, P.H., Hardeman, M., Vernick, K.D., Sauerwein, R.W., Preiser, P.R., Mercereau-517 
Puijalon, O., Buffet, P., Alano, P., Lavazec, C., 2012. A switch in infected erythrocyte deformability at 518 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
25 
 
the maturation and blood circulation of Plasmodium falciparum transmission stages. Blood 119, e172-519 
180. 520 
Trager, W., Jensen, J.B., 1976. Human malaria parasites in continuous culture. Science 193, 673-675. 521 
Watermeyer, J.M., Hale, V.L., Hackett, F., Clare, D.K., Cutts, E.E., Vakonakis, I., Fleck, R.A., 522 
Blackman, M.J., Saibil, H.R., 2016. A spiral scaffold underlies cytoadherent knobs in Plasmodium 523 
falciparum-infected erythrocytes. Blood 127, 343-351. 524 
Waters, S.P., Dalling, M.J., 1983. Purification and Characterization of an Iminopeptidase from the 525 
Primary Leaf of Wheat (Triticum aestivum L.). Plant Physiol 73, 1048-1054. 526 
World Health Organization, 2015. World Malaria Report, World Health Organization, Geneva  527 
Wu, Y., Sifri, C.D., Lei, H.H., Su, X.Z., Wellems, T.E., 1995. Transfection of Plasmodium falciparum 528 
within human red blood cells. Proc Natl Acad Sci U S A 92, 973-977. 529 
Yoshimoto, T., Kabashima, T., Uchikawa, K., Inoue, T., Tanaka, N., Nakamura, K.T., Tsuru, M., Ito, 530 
K., 1999. Crystal structure of prolyl aminopeptidase from Serratia marcescens. J Biochem 126, 559-531 
565. 532 
  533 
Figure Legends 534 
Fig 1. A sequence alignment was used to construct a theoretical structural model of the catalytic 535 
domain of PfPAP. A) ClustalX alignment of PF3D7_1401300 (N-terminal PEXEL region removed) 536 
against the prolyl aminopeptidase from S. marcescens (UniProtKB 032449). Catalytic triad residues 537 
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(S249, D402, H430) are highlighted. B) Crystal structure of prolyl aminopeptidase from S. marcescens 538 
(PDB code 1QTR). Catalytic residues are numbered and shown as Corey, Pauling, Koltun (CPK) 539 
surfaces. The protein backbone is shown as a thin tube. C). Initial model structure of the putative prolyl 540 
aminopeptidase PF3D7_1401300. Catalytic residues are numbered and shown as CPK surfaces. The 541 
protein backbone is shown as a thin tube. 542 
 543 
Fig 2. Purification of a functionally active recombinant PfPAP. A). Purification of active rPfPAP. 544 
M, molecular size markers; S, soluble supernatant; W, washes; E, eluted rPfPAP. Purified protein 545 
migrates at ~45 kDa. B). Immunoblot confirmed identity of eluted purified rPfPAP with primary mouse 546 
anti-histidine antibody and secondary goat anti-mouse horseradish peroxidase antibody. C). Enzyme 547 
assays with the fluorogenic peptide substrate H-Pro-NHMec demonstrate that the rPfPAP exhibits 548 
typical Michaelis-Menten enzymatic kinetics with a Km constant of 403.6 µM. 549 
 550 
Fig 3. PfPAP is transcribed throughout the intraerythrocytic asexual lifecycle and exported into 551 
the host RBC. A). Northern blot analysis of PF3D7_1401300 transcription, RNA was probed with the 552 
full length coding region of the gene. R = ring stage parasites. ET = early trophozoite parasites, LT = 553 
late trophozoite parasites, S = schizont stage parasites. Analysis reveals transcription in all stages. B). 554 
Quantitative analysis of PfPAP transcription relative to reference genes demonstrates highest 555 
transcription in early stages of the intra-erythrocytic asexual life cycle C). Western blot of 3D7 556 
and 3D7_PAP-KO parasites probed with anti PfPAP shows the loss of protein expression in the 557 
knockout line. REX1 protein expression in both clones was used to demonstrate protein loading. C). 558 
Direct fluorescence of transgenic parasites expressing PF3D7_1401300 C-terminally tagged with GFP. 559 
BF = bight field, GFP = GFP fluorescence, Nuclei = nuclear staining with Hoechst, Merge = merge of 560 
the previous images. Bar 5µm. 561 
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 562 
Fig 4. Targeted gene disruption of PfPAP changes the filterability of the infected RBCs but not 563 
the expression or localization of KAHRP, REX1, and PfEMP-3. A). Analysis of filterability of 564 
3D7_PAP-KO through micro beads designed to mimic the splenic microcirculation. Samples were 565 
measured at 16, 18, 20 and 26 h post invasion. Data are presented as mean percentage of parasites 566 
present in the flow-through relative to the starting parasitemia (+ SEM; from 3 triplicate experiments). 567 
B). Immunofluorescence using anti-KAHRP, REX1, and PfEMP-3 antibodies on 3D7 and 3D7_PAP-568 
KO show no difference in the location of these proteins. C). Electron microscopy of 3D7_PAP-KO 569 
showing electron dense structures at the surface of the infected erythrocyte indicative of the presence of 570 
knobs. Bars are 5 µm. 571 
 572 
Fig 5.   Targeted gene disruption of PfPAP reduces CD36 cytoadhere under flow conditions A). 573 
Intact 3D7 and  3D7_PAP-KO infected RBCs were subjected to treatment with PBS (P) or trypsin (T) 574 
or trypsin plus inhibitor (i), then extracted and subjected to SDS-PAGE and probed using an antibody 575 
recognizing the ATS domain of PfEMP-1. PfEMP-1 cleavage products are indicated. B) 3D7 and 576 
 3D7_PAP-KO-infected RBCs adhere to recombinant CD36 at comparable levels under static 577 
conditions C). 3D7_PAP-KO parasites have a reduced ability to cytoadhere to CD36 under flow 578 
conditions. Adherence under flow conditions was assessed at flow rates equivalent to shear stresses of 579 
0.1 and 0.05 Pa. The mean numbers (from 3 separate experiments) of parasites bound per mm2 are 580 
shown (+ SEM). 581 
 582 
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• The pathology of Falciparum malaria is associated with the remodelling of host RBCs 
• We investigated the role of PfPAP, a putative proline aminopeptidase in this process 
• PfPAP contains a predicted protein export element and is non-syntenic with other 
malaria species 
• Our data confirm that PfPAP is a proline aminopeptidase that it is exported into the 
host RBC  
• Genetic deletion of PfPAP suggests it plays a role in RBC rigidification and 
cytoadhesion 
